✨ Free AI Report
Harvard Bioscience, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Harvard Bioscience, Inc.
Company Research

Harvard Bioscience, Inc.: Business Overview, Financials & Competitive Analysis

Harvard Bioscience, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Undervalued biotech equipment supplier executing operational turnaround with improving margins, but faces profitability headwinds and execution risks. Q4 2025 revenue was $23.7M with gross margin at 60% and adjusted EBITDA of $3.8M up 27% YoY. However, the company faces profitability challenges and recently underwent significant restructuring. Recent debt refinancing.

What is Harvard Bioscience, Inc.'s industry? Harvard Bioscience, Inc. (harvardbioscience.com) operates in Life Sciences Equipment & Instrumentation / Biotech Research Tools. AskCyborg classifies Harvard Bioscience, Inc. under Life Sciences Equipment & Instrumentation / Biotech Research Tools in its company registry.

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. The company develops, manufactures and sells technologies, products and services u...

5/ 10Mixed

Cyborg Score thesis

Undervalued biotech equipment supplier executing operational turnaround with improving margins, but faces profitability headwinds...

Read the full analyst-debate transcript →
Industry Life Sciences Equipment & Instrumentation / Biotech Research Tools
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Harvard Bioscience, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Harvard Bioscience, Inc.

AskCyborg analysts argue the bull and bear cases for Harvard Bioscience, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Harvard Bioscience, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Harvard Bioscience, Inc. Overview

Pro stress-test →

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. The company develops, manufactures and sells technologies, products and services used in research, drug and therapy discovery, bio-production and preclinical testing.

Strategic Profile

Pro stress-test →

The company's product portfolio is broken into five market segments: Fluidics, Laboratory Equipment & Supplies, Molecular Analysis, Cell Analysis, and Physiology. In summer 2025 the board was reconstituted with a new CEO appointed, and in December 2025 the company successfully refinanced its debt, obtaining a $40 million credit facility with BroadOak Capital.

Competitive Landscape

Pro stress-test →

Harvard Bioscience operates in the life sciences equipment and instrumentation market, competing against larger diversified life sciences companies and specialized equipment manufacturers. The company differentiates through proprietary platforms in cellular and molecular analysis, physiology monitoring, and electrophysiology, serving academic institutions, pharmaceutical companies, and biotech firms globally.

Industry Context

Harvard Bioscience, Inc. operates in Life Sciences Equipment & Instrumentation / Biotech Research Tools.

Key facts

Founded: 1901 · Headquarters: Holliston, MA, United States · Employees: 343 · Revenue: $85-90M · Market cap: $26-35M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Harvard Bioscience, Inc..

  • Q4 2025 gross margin improved to 60% (high end) with adjusted EBITDA up 27% YoY, indicating positive operational momentum.
  • Manufacturing consolidation closing Holliston MA facility, shifting US production to Minneapolis, with completion targeted by Q1 2027 and expected $3-4M in annual savings thereafter.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Q4 2025 preliminary results announced with $23.7M revenue and 60% gross margin exceeding guidance
  • Dec 2025Refinanced debt with $40M credit facility from BroadOak Capital; all loans mature Dec 17, 2029
  • +2 moreTrack every material event for Harvard Bioscience, Inc. as it happens. Explore monitoring →
Get alerted when Harvard Bioscience, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Electrophysiology SystemsPatch clamp and electrophysiology recording systems→Infusion SystemsSyringe pumps and peristaltic infusion equipment→Cellular Analysis PlatformsMicroelectrode array systems and cellular analysis→

Compare Harvard Bioscience, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Harvard Bioscience, Inc. operates in Life Sciences Equipment & Instrumentation / Biotech Research Tools. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences Equipment & Instrumentation / Biotech Research Tools research →
NEW · MCP server

Ask your AI assistant about Harvard Bioscience, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Harvard Bioscience, Inc. and its top competitor on Cyborg Score”
“What did Harvard Bioscience, Inc. do this quarter?”
“Is Harvard Bioscience, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Harvard Bioscience, Inc. do?+
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. The company develops, manufactures and sells technologies, products and services u...
What is Harvard Bioscience, Inc.'s Cyborg Score?+
Harvard Bioscience, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Harvard Bioscience, Inc.'s main competitors?+
Named competitors include Electrophysiology Systems, Infusion Systems, Cellular Analysis Platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full Harvard Bioscience, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Harvard Bioscience, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Harvard Bioscience, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.